MAVEN

Komodo Health Expands Its Enterprise Strategy and Transformation Capabilities, Delivering Unmatched Software and Consulting Expertise for Life Sciences Enterprises

Retrieved on: 
Monday, December 18, 2023

Today, Komodo Health announces the expansion of its enterprise engagement capabilities and launches a new, dedicated Enterprise Strategy and Transformation team.

Key Points: 
  • Today, Komodo Health announces the expansion of its enterprise engagement capabilities and launches a new, dedicated Enterprise Strategy and Transformation team.
  • The foundation of Komodo Professional Services comes out of the company’s 2021 acquisition of Mavens and its industry-leading Life Sciences technology expertise.
  • A global top 20 pharma company’s Medical Information team, for example, partnered with Komodo to configure its global publications strategy using Komodo Publications Planning.
  • Komodo’s purpose-built, highly configurable, and connected solution replaced the existing siloed systems and streamlined resources and publication strategy — all while accelerating workflows and ensuring quality.

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

Retrieved on: 
Monday, November 6, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies (Terumo BCT) announce a collaboration to enable on-line monitoring of critical process parameters in Terumo BCT’s Quantum Flex Cell Expansion System.

Key Points: 
  • 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies (Terumo BCT) announce a collaboration to enable on-line monitoring of critical process parameters in Terumo BCT’s Quantum Flex Cell Expansion System.
  • Cell and gene therapy developers are increasingly looking to automation to improve manufacturing efficiency, simplify workflows and reduce costs.
  • “Combining our Quantum Flex platform with 908 Devices’ on-line monitoring will help cell therapy manufacturers reduce time-consuming manual steps that increase manufacturing costs and risks,” said Kathie Schneider, Director, Global Commercial Lead, Cell Therapy Technologies at Terumo BCT.
  • “We continue to collaborate with industry experts to further enhance our solution offering to solve industry challenges.”

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

Retrieved on: 
Monday, September 18, 2023

MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control, with no modeling and development required.

Key Points: 
  • MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control, with no modeling and development required.
  • MAVERICK offers all the advantages of Raman spectroscopy without the cost and complexities associated with conventional spectroscopic methods.
  • MAVERICK’s purpose-built de novo models automatically process Raman spectra from a wide variety of culture media types and cell lines, delivering actionable process parameters or direct process control actions.
  • MAVERICK is part of 908 Devices’ suite of devices to help expedite bioprocessing development, including MAVEN – introduced earlier this year -- and REBEL .

MAVEN Project and Safety Net Connect Partner to Increase Equitable Access to Specialty Care in Marginalized Communities

Retrieved on: 
Thursday, June 8, 2023

Safety Net Connect (SNC), a leading provider of advanced virtual care solutions, is honored to support the critical work of MAVEN Project, a 501c3 enabling specialists to connect with primary care providers working in traditionally marginalized communities.

Key Points: 
  • Safety Net Connect (SNC), a leading provider of advanced virtual care solutions, is honored to support the critical work of MAVEN Project, a 501c3 enabling specialists to connect with primary care providers working in traditionally marginalized communities.
  • Utilizing SNC’s Converge solution to provide seamless asynchronous and synchronous communication capability, MAVEN Project connects their team of over 165 expert physician volunteers to safety net clinicians.
  • MAVEN Project’s unique and holistic approach reduces patient barriers to care, including long wait times, travel, and costs that often accompany specialist referrals.
  • “MAVEN Project facilitates peer-to-peer connections between frontline providers and our volunteer physicians to address inequities in health care,” shared David Segal, CEO of MAVEN Project.

Minority-Owned Nativo Joins MAVEN Database As Certified Diversity Supplier

Retrieved on: 
Wednesday, June 7, 2023

MAVEN, launched in 2008 in collaboration with the four major advertising agency holding companies to facilitate media ownership and diversity reporting.

Key Points: 
  • MAVEN, launched in 2008 in collaboration with the four major advertising agency holding companies to facilitate media ownership and diversity reporting.
  • As more and more organizations adopt supplier diversity programs, being included in the MAVEN Diversity supplier network ensures that Nativo is accessible to advertisers, agencies and publishers actively seeking partnerships with diverse suppliers.
  • "We applaud the work that Media Framework is doing with their MAVEN database," said Justin Choi, Founder and CEO of Nativo.
  • In addition to being added to the MAVEN Diversity platform, Nativo is also certified as a Minority Business Enterprise by the National Minority Supplier Development Council (NMSDC) and was recognized by Comparably as one of its Best Companies for Diversity and Best Companies for Women in 2023.

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

Retrieved on: 
Tuesday, March 7, 2023

Revenue of $11.6 million for the fourth quarter 2022, compared to $15.8 million in the fourth quarter 2021, which included an $8 million shipment of MX908 devices to the U.S. Army in the fourth quarter 2021.

Key Points: 
  • Revenue of $11.6 million for the fourth quarter 2022, compared to $15.8 million in the fourth quarter 2021, which included an $8 million shipment of MX908 devices to the U.S. Army in the fourth quarter 2021.
  • Expanded total installed base to 2,385 devices with 68 devices placed during the fourth quarter 2022.
  • Gross profit was $5.9 million for the fourth quarter of 2022, compared to $9.1 million for the corresponding prior year period.
  • 908 Devices will host a conference call to discuss the fourth quarter and full year 2022 financial results before market open on Tuesday, March 7, 2023 at 5:30 am Pacific Time / 8:30 am Eastern Time.

908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control

Retrieved on: 
Tuesday, January 17, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced the launch of MAVEN , a device for on-line monitoring and control of glucose and lactate in cell culture and fermentation processes.

Key Points: 
  • 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced the launch of MAVEN , a device for on-line monitoring and control of glucose and lactate in cell culture and fermentation processes.
  • This enables real-time control of substrate feeding to maintain optimal nutrient and metabolite concentrations, even at very low levels.
  • Specifically for glucose and lactate, we are providing precision measurements that preserve sample integrity and have low limits of detection.
  • Additionally, check out 908 Devices at industry events, including Advanced Therapies Week (booth #513) and PepTalk (booth #313).

The MolinaCares Accord Partners with MAVEN Project to Address Health Equity in New Mexico

Retrieved on: 
Thursday, January 5, 2023

The MolinaCares Accord (“MolinaCares”) has partnered with MAVEN Project to give providers access to training and volunteer specialists that will result in high-quality, specialty health care for underserved populations at 10 clinics throughout New Mexico.

Key Points: 
  • The MolinaCares Accord (“MolinaCares”) has partnered with MAVEN Project to give providers access to training and volunteer specialists that will result in high-quality, specialty health care for underserved populations at 10 clinics throughout New Mexico.
  • “Specialty care remains a daunting challenge for underserved communities, especially those living in rural areas,” said David Segal, CEO of MAVEN Project.
  • MAVEN Project offers providers access to consultations in more than 60 specialty areas, ranging from mental and behavioral health to infectious disease, oncology, and endocrinology.
  • Additionally, the MAVEN Project model reduces costs for patients by eliminating the need for unnecessary out-of-clinic specialty care referrals in nearly three out of four consultations.

RIVET UTILITY MAVEN JUMPSUIT SELECTED AS ONE OF OPRAH'S FAVORITE THINGS 2022

Retrieved on: 
Wednesday, November 2, 2022

LOS ANGELES, Nov. 1, 2022 /PRNewswire/ -- Rivet Utility announced today that the MAVEN Jumpsuit is included in 2022 Oprah's Favorite Things holiday gifts list, featured on OprahDaily.com and in the Winter issue of O Quarterly, on newsstands November 1. The Oprah's Favorite Things annual list is a must-have holiday shopping guide with the most decadent desserts, ingenious gadgets, and finest finds in home, fashion, and beauty. This year's list features a variety of wonderful items for you and your loved ones, most of which have been selected from small businesses. To shop the full list of items please visit: https://www.oprahdaily.com/oprah-favorite-things-2022. Rivet Utility's The MAVEN Jumpsuit will be available for purchase at www.rivetutility.com, and in the Oprah's Favorite Things gift guide exclusively in Amazon's store at amazon.com/oprah, as well as via the Amazon shopping app for customers to conveniently shop anytime, anywhere.

Key Points: 
  • LOS ANGELES, Nov. 1, 2022 /PRNewswire/ --Rivet Utility announced today that the MAVEN Jumpsuit is included in 2022 Oprah's Favorite Things holiday gifts list , featured on OprahDaily.com and in the Winter issue of O Quarterly, on newsstands November 1.
  • As with all Rivet Utility Jumpsuits, the MAVEN is made in Downtown Los Angeles and retails for $295.
  • The Winter issue of O Quarterly, featuring the Rivet Utility MAVEN Jumpsuit on this year's list, hits newsstands nationwide on November 1.
  • Rivet Utility is committed to creating quality productssustainablyandethicallyand is currently sold on Net-A-Porter, GOOP, Saks, Bergdorf Goodman and Neiman Marcus.

The MolinaCares Accord Invests Over $400,000 in MolinaCares for Families Initiative to Improve Access to Care in New Mexico

Retrieved on: 
Tuesday, October 18, 2022

The MolinaCares Accord (MolinaCares), in collaboration with Molina Healthcare of New Mexico , today launched its MolinaCares for Families initiative with an initial commitment of over $400,000 to improve access to care for families across New Mexico.

Key Points: 
  • The MolinaCares Accord (MolinaCares), in collaboration with Molina Healthcare of New Mexico , today launched its MolinaCares for Families initiative with an initial commitment of over $400,000 to improve access to care for families across New Mexico.
  • MolinaCares for Families expands access to care for mothers, newborns, and individuals with behavioral health needs throughout our state, said Carolyn Ingram, plan president of Molina Healthcare of New Mexico.
  • Our goal through this initiative is to remove barriers to equitable care by making critical services available to New Mexicans who need it most.
  • Many New Mexicans struggle with access to care due to socioeconomic factors, shortages in specialty care providers, and vast rural regions.